Trading Signals: UTHR Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)( United Therapeutics Corp)
| UTHR latest price $203.8800 (0.93%) ($200.9400 - $203.8800) on Fri. Apr. 16, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.68% (three month average) | RSI | 77 | Latest Price | $203.8800(0.93%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | UTHR advances 7.2% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support UTHR advance at 0% a week (0% probability) XLV(35%) VFMO(28%) VYM(28%) IBB(26%) XBI(26%) | Factors Impacting UTHR price | UTHR will decline at least -1.34% in a week (0% probabilities). VIXM(-21%) VXX(-16%) UUP(-11%) BND(-4%) TLT(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.34% (StdDev 2.68%) | Hourly BBV | 1.7 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $201.3(1.28%) | 10 Day Moving Average | $199.02(2.44%) | 20 Day Moving Average | $185.52(9.9%) | To recent high | 0% | To recent low | 31% | Market Cap | $9.043b | | | | United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD. |